Clinical Trials
4 trialsNCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT02324803 2014-12-24
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Southern China Urology Cancer Consortium
Phase 2 Unknown
NCT01577784 2014-03-12
Pazopanib in Second-line Therapy in Renal Cell Carcinoma
Associació per a la Recerca Oncologica, Spain
Phase 2 Unknown
NCT01377298 2011-06-21
Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital
Phase 2 Unknown